Dr. Hönle AG reported earnings results for the full year ended September 30, 2021. For the full year, the company reported sales was EUR 115.22 million compared to EUR 93.9 million a year ago. Net loss was EUR 4.82 million compared to net income of EUR 5.68 million a year ago.

Basic loss per share from continuing operations was EUR 0.8 compared to basic earnings per share from continuing operations of EUR 1.02 a year ago. Diluted loss per share from continuing operations was EUR 0.8 compared to diluted earnings per share from continuing operations of EUR 1.02 a year ago.